The recommendations for pediatric rheumatology patients address various treatment options and provide general guidance, as well as direction for when to start, stop or reduce medications.
Gretchen Henkel is an award-winning health and medical journalist based in California. She reports on clinical and outcomes research and practice management issues, as well as patient-centered and culturally competent care for various specialties, including hospital medicine, rheumatology, oncology, otolaryngology and long-term care. As an editorial consultant for the SAMHSA-funded National Child Traumatic Stress Network, she develops content for toolkits on assessment and treatment of childhood abuse and trauma, and is the managing editor of the NCTSN quarterly newsletter, IMPACT.
Articles by Gretchen Henkel
Spring 2020’s Awards, Appointments & Announcements in Rheumatology
Keith Sullivan, MD, Receives Lifetime Achievement Award Mentorship, collaboration and a quest for cure shine through as major themes in the distinguished career of Keith M. Sullivan, MD, the James B. Wyngaarden Professor of Medicine, Duke University Medical Center, Durham, N.C. On Friday, Feb. 21, those themes dominated his acceptance speech when he received a…
Winter 2020’s Awards, Appointments & Announcements in Rheumatology
2019 Lupus Foundation of America Gary S. Gilkeson Career Development Awards Emily Smitherman, MD, assistant professor, pediatric rheumatology, University of Alabama at Birmingham, and Children’s of Alabama, one of four recipients of the Gary S. Gilkeson Career Development Awards, is interested in identifying predictors for differences in disease activity within the pediatric population. To accomplish…
Study Finds an Indirect Association Between Sleep & Inflammation
In a study in Arthritis Care & Research, researchers showed an indirect association between osteoarthritis (OA) and sleep health in older men.1 In those participants with OA, the condition is associated with poorer sleep health, as well as a 16% higher incidence of elevated C-reactive protein and 12% higher odds of having elevated interleukin 6….
Fall 2019’s Awards, Appointments & Announcements in Rheumatology
J. Michelle Kahlenberg Receives Presidential Early Career Award for Scientists & Engineers (PECASE) A physician scientist and associate professor of internal medicine in the Division of Rheumatology at the University of Michigan in Ann Arbor, J. Michelle Kahlenberg, MD, PhD, is a 2019 recipient of the prestigious PECASE award. Dr. Kahlenberg, who also holds the…
Summer 2019’s Awards, Appointments & Announcements in Rheumatology
Betty Diamond, MD, Recognized as Distinguished Fellow by American Association of Immunologists At its annual meeting in May in San Diego, the American Association of Immunologists (AAI) recognized Betty Diamond, MD, as a distinguished fellow. Dr. Diamond is professor and head of the Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases at the Feinstein Institutes for…
Recent Awards & Appointments in Rheumatology
Prestigious Carol Nachman Prize for Research in Rheumatology Awarded to Ellen Gravallese On May 10, Ellen M. Gravallese, MD, the Myles J. McDonough Chair in Rheumatology and chief of the Division of Rheumatology at University of Massachusetts Medical School, Worcester, was awarded the prestigious Carol Nachman Prize for lifetime achievement in rheumatology research in Wiesbaden,…
Interstitial Lung Disease: What Rheumatologists Need to Know
In the past decade, the treat-to-target concept has gained broad acceptance. Both the ACR and European League Against Rheumatism (EULAR) management recommendations include adding biologic therapies to the treatment regimen for rheumatoid arthritis (RA) patients who do not sufficiently respond to methotrexate monotherapy. “What EULAR says is that if [methotrexate use fails], you should essentially…
More Data for Treat to Target: Post-Hoc Analysis of Large RA Clinical Trials Supports Treat-to-Target Recommendations
A post-hoc analysis of data from two large clinical trials supports treat-to-target recommendations for patients with rheumatoid arthritis. The research found baseline disease activity was the strongest predictor of a patient’s insufficient response to initial therapy at six months…
Metrics in Rheumatology: Focus on Harold E. (Hal) Paulus, MD
We have just learned that Dr. Hal Paulus passed away on April 5, 2019. We are reposting this story today in his memory and will share additional information as we learn it.
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 14
- Next Page »